Oncology Research Open Access Editors-in-Chief: Edward Chu, Enrico Mini
Home Oncology Research All Issues Volume 33 Issue 5
Volume 33 Issue 5, April 2025
PP. 995-1253
|
21 articles
Commentary
Commentary | Open Access
GlycoRNA: A new player in cellular communication
Published: 18 April 2025
2025, 33(5): 995-1000
Viewpoint
Viewpoint | Open Access
The SS18-SSX fusion oncoprotein: Friend and foe in targeted therapy for synovial sarcoma
Published: 18 April 2025
2025, 33(5): 1001-1005
Review
Review | Open Access
Promising roles of vitamin D receptor and APRO family proteins for the development of cancer stem cells targeted malignant tumor therapy
Published: 18 April 2025
2025, 33(5): 1007-1017
Review | Open Access
Current innovations in head and neck cancer: From diagnostics to therapeutics
Published: 18 April 2025
2025, 33(5): 1019-1032
Review | Open Access
Non-coding RNAs as potential mediators of resistance to lung cancer immunotherapy and chemotherapy
Published: 18 April 2025
2025, 33(5): 1033-1054
Review | Open Access
A review on pathobiology of circulating tumour plasma cells: The sine qua non of poor prognosis in plasma cell neoplasms
Published: 18 April 2025
2025, 33(5): 1055-1068
Review | Open Access
Classical biomarkers and non-coding RNAs associated with diagnosis and treatment in gastric cancer
Published: 18 April 2025
2025, 33(5): 1069-1089
Review | Open Access
Research progress on cancer-associated fibroblasts in osteosarcoma
Published: 18 April 2025
2025, 33(5): 1091-1103
Review | Open Access
Immunomodulatory behavior of CircRNAs in tumor microenvironment
Published: 18 April 2025
2025, 33(5): 1105-1119
Article
Article | Open Access
Splicing factor PTBP1 promotes hepatocarcinogenesis via oncogenic splice-switching of MAPT
Published: 18 April 2025
2025, 33(5): 1121-1133
Article | Open Access
OTUB2 promotes proliferation and metastasis of triple-negative breast cancer by deubiquitinating TRAF6
Published: 18 April 2025
2025, 33(5): 1135-1147
Article | Open Access
Death domain-associated protein (Daxx) impairs colon cancer chemotherapy by inhibiting the cGAS-STING pathway
Published: 18 April 2025
2025, 33(5): 1149-1159
Article | Open Access
Oncolytic adenovirus H101 enhances the anti-tumor effects of PD-1 blockade via CD47 downregulation in tumor cells
Published: 18 April 2025
2025, 33(5): 1161-1172
Article | Open Access
Mycobacterial antigen Ag85B restrains Hodgkin lymphoma tumor growth by inhibiting autophagy
Published: 18 April 2025
2025, 33(5): 1173-1187
Article | Open Access
The alternatively spliced diacylglycerol kinase gamma-Δ exon13 transcript generated under hypoxia promotes glioblastoma progression
Published: 18 April 2025
2025, 33(5): 1189-1198
Article | Open Access
A novel Wnt/β-catenin signaling gene signature for progression and metastasis of gastric cancer
Published: 18 April 2025
2025, 33(5): 1199-1215
Article | Open Access
Anticancer effects of SH003 and its active component Cucurbitacin D on oral cancer cell lines via modulation of EMT and cell viability
Published: 18 April 2025
2025, 33(5): 1217-1227
Article | Open Access
The synergistic antitumor effect of Karanahan technology and in situ vaccination using anti-OX40 antibodies
Published: 18 April 2025
2025, 33(5): 1229-1248
Correction
Correction | Open Access
Correction: Silencing of the long non-coding RNA LINC00265 triggers autophagy and apoptosis in lung cancer by reducing protein stability of SIN3A oncogene
Published: 18 April 2025
2025, 33(5): 1249-1250
Retraction
Retraction | Open Access
Retraction: lncRNA FEZF1-AS1 Is Associated with Prognosis in Lung Adenocarcinoma and Promotes Cell Proliferation, Migration, and Invasion
Published: 18 April 2025
2025, 33(5): 1251-1252
Retraction | Open Access
Retraction: Swainsonine inhibits invasion and the EMT process in esophageal carcinoma cells by targeting twist1
Published: 18 April 2025
2025, 33(5): 1253